Precipio Inc

NASDAQ:PRPOUnited States

Precipio, Inc. is a healthcare biotechnology company that is focused on cancer diagnostics. It develops and sells diagnostic products, reagents and services that improve the accuracy and efficiency of diagnostics, and lead to fewer misdiagnoses. The Company’s technologies include HemeScreen and IV-Cell. IV-Cell is a cell culture media that addresses the problem of diagnostic mistakes through the process of selective culturing. IV-Cell is a universal media that enables simultaneous culturing of all four hematopoietic cell lineages. Its technology enables testing to be completed in one rapid scanning process. The HemeScreen panels test for the presence of various mutations. In developing HemeScreen, it focused on improving the economics of providing blood cancer diagnostic tests and reducing laboratory technician time consumed in the testing process. The Company’s laboratory and research and development (R&D) facilities are located in New Haven, Connecticut and Omaha, Nebraska.

Contact Information

Headquarters

4 Science ParkNEW HAVEN, CT, United States 06511

Phone

203-787-7888

Fax

302-655-5049

Executives

Independent Chairman of the Board

Richard Sandberg

Chief Executive Officer, Founder, Director

Ilan Danieli

Interim Chief Financial Officer

Matthew Gage

Chief Operations Officer

Ahmed Zaki Sabet

Chief Legal Counsel and People Officer

Miri Chiko-Radomski